Randomized trial of aspirin, sibrafiban, or both for secondary prevention after acute coronary syndromes.

阅读量:

34

作者:

K Newby

展开

摘要:

Combining aspirin with LDS did not improve outcomes after acute coronary syndromes and caused more bleeding compared with aspirin alone. There was a trend toward increased mortality in this group and a significant increase in the high-dose arm.

展开

DOI:

10.1016/S1062-1458(01)00370-1

被引量:

329

年份:

2001

通过文献互助平台发起求助,成功后即可免费获取论文全文。

相似文献

参考文献

引证文献

来源期刊

Acc Current Journal Review
September–October 2001

引用走势

2002
被引量:34

辅助模式

0

引用

文献可以批量引用啦~
欢迎点我试用!

引用